Distinguishing atypical focal areas of signal intensity from probable low-grade gliomas in the posterior fossa of children with neurofibromatosis type 1
Archives de Pédiatrie · 2025-10 · 32 (7) · 463-468
DOI: 10.1016/j.arcped.2025.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives de Pédiatrie, 2025-10. Verfasst von Agnès Viguier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Département de neuropédiatrique et centre de réference maladie rare Neurofibromatose de type 1 de l'enfant, hôpital des enfants, CHRU Toulouse, Franc…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: Focal areas of signal intensity (FASI) in the posterior fossa are common in children with neurofibromatosis type 1 (NF1). These can be difficult to distinguish from tumour processes when they are atypical. This study aimed to describe the initial radiological features of atypical posterior fossa FASI, depending on the clinical and radiological evolution of the lesion. METHODS: We conducted a multicentre retrospective study of NF1 children with atypical FASI in the posterior fossa. The lesions were classified according to their evolution over time: 'non-neoplastic FASI' if they regressed, or 'possible neoplastic FASI' if they remained stable or progressed. RESULTS: Forty-two lesions from 31 patients were analyzed. The mean follow-up period between the first and last MRI scans was 7.1 years. Twenty-one atypical FASI were classified as 'non-neoplastic FASI' and 21 as 'possible neoplastic FASI'. Younger age at diagnosis, pontine location, and blurred contours were more indicative of 'non-neoplastic FASI' on the initial MRI, whereas symptomatic, cystic or exophytic lesions, the presence of enhancement after gadolinium injection, sharp contours, and clear mass effect were more indicative of a 'possible neoplastic FASI'. Unexpectedly, abnormal initial spectroscopy and small mass effect could be found in 'non-neoplastic FASI', as could the presence of hypointensity on T1-weighted images. CONCLUSION: This study is important in specifying which posterior fossa hyperintensities on T2-weighted MRIs require specific clinical and radiological follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de neuropédiatrique et centre de réference maladie rare Neurofibromatose de type 1 de l'enfant, hôpital des enfants, CHRU Toulouse, France.
- Neuro-oncologie pédiatrique, hôpital des enfants, CHRU Toulouse, France.
- Neuro-radiologie pédiatrique, hôpital Pierre Paul Riquet, CHRU Toulouse, France.
- Neuroradiologie, hôpital Gui de Chauliac, CHRU Montpellier, France.
- Neurochirugie pédiatrique, hôpital Pierre Paul Riquet, CHRU Toulouse, France.
- Neuropédiatrie, CHRU Montpellier, PhyMedExp, CNRS, INSERM, Université de Montpellier, France.
Zitieren
APA
Viguier, A., Estublier, B., Bertozzi, A. I., Gambart, M., Sevely, A., Leboucq, N., Antherieu, P., Rivier, F., Meyer, P., Bessis, D., Chaix, Y., & Baudou, E. (2025). Distinguishing atypical focal areas of signal intensity from probable low-grade gliomas in the posterior fossa of children with neurofibromatosis type 1. Archives de Pédiatrie, 32(7), 463-468. https://doi.org/10.1016/j.arcped.2025.05.010
Vancouver
Viguier A, Estublier B, Bertozzi AI, Gambart M, Sevely A, Leboucq N, et al. Distinguishing atypical focal areas of signal intensity from probable low-grade gliomas in the posterior fossa of children with neurofibromatosis type 1. Archives de Pédiatrie. 2025;32(7):463-468. doi:10.1016/j.arcped.2025.05.010
BibTeX
@article{Viguier2025,
author = {Viguier, Agnès and Estublier, Bastien and Bertozzi, Anne-Isabelle and Gambart, Marion and Sevely, Annick and Leboucq, Nicolas and Antherieu, Pierre and Rivier, François and Meyer, Pierre and Bessis, Didier and Chaix, Yves and Baudou, Eloïse},
title = {Distinguishing atypical focal areas of signal intensity from probable low-grade gliomas in the posterior fossa of children with neurofibromatosis type 1},
journal = {Archives de Pédiatrie},
year = {2025},
volume = {32},
number = {7},
pages = {463--468},
doi = {10.1016/j.arcped.2025.05.010}
}
EUVIMED